Prevalence, Costs And Services of Comorbid Conditions Associated with Functional Dyspepsia
Brook, R., Talley, N., Choung, R., Smeeding, J., Melkonian, A., Kleinman, N.
ISPOR 15th Annual International Meeting
Atlanta, GA
May 17, 2010
Poster #PGI3.
Functional Dyspepsia Decrease Productivity and Increased Medical costs
Brook, R., Talley, N., Choung, R., Smeeding, J., Melkonian, A., Kleinman, N.
ISPOR 15th Annual International Meeting
Atlanta, GA
May 17, 2010
Poster #PGI12.
Direct Medical Costs and the Likelihood of Health Service Utilization Before and After Initiation of Interferon Beta1A-IM Treatment among Persons with Multiple Sclerosis (MS)
Brook, R., Rajagopalan, K., Kleinman, N., Beren, I.
International Society of Pharmacoeconomics and Outcomes Research 14th Annual International Meeting
Orlando, FL
May 20, 2009
Direct Medical Costs and the Likelihood of Health Service Utilization Before and After Initiation of Interferon Beta1A-IM Treatment among Persons with Multiple Sclerosis (MS)
Brook, R., Rajagopalan, K., Kleinman, N., Beren, I.
International Society of Pharmacoeconomics and Outcomes Research 14th Annual International Meeting
Atlanta, GA
May 27-30, 2009
Cost of Illness for Fibromyalgia in the Workforce: Medical, Pharmacy, and Absence Cost Comparisons in Employees with or without Fibromyalgia
Kleinman, N., Lynch, W., Melkonian, A., Harnett, J., Andrews, L., Silverman, S.
ACOEM Conference
San Diego, CA
April 28, 2009
Annual Direct and Indirect Cost of Illness in Employees with Irritable Bowel Syndrome plus Constipation
Brook, R., Kleinman, N., Melkonian, A., Baran, R.
American College of Gastroenterology
Orlando, FL
October 3-8, 2008
The Prevalence and Costs to Treat Comorbidities in Persons with Constipation and Irritable Bowel Syndrome with Constipation in the 6 Months After Diagnosis: An Employer’s Perspective
Brook, R., Kleinman, N., Melkonian, A., Talley, N., Locke, G., Baran, R.
American College of Gastroenterology
Orlando, FL
October 3-8, 2008
Health Benefit Costs Among Employees With Multiple Sclerosis
Kleinman, N., Rajagopalan, K., Brook, R., Melkonian, A.
Consortium of Multiple Sclerosis Centers
Denver, CO
May 30, 2008
Pediatric Asthma: An Employer Perspective on Annual Employee and Dependent Costs for Medical Care and Prescription Drugs
Kleinman, N., Brook, R., Ramachandran, S., Wagner, S.
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
Toronto, Ontario, Canada
May 6, 2008
Prevalence and Costs of Comorbidities Among Persons with and without Multiple Sclerosis: An Analysis of the AHRQ Major and Specific Diagnostic Categories
Brook, R., Rajagopalan, K., Kleinman, N., Melkonian, A.
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
Toronto, Ontario, Canada
May 5, 2008
Severity of Illness Among Persons with Multiple Sclerosis: An Analysis of Cost Quintiles
Brook, R., Rajagopalan, K., Kleinman, N., Melkonian, A.
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
Toronto, Ontario, Canada
May 5, 2008
Comparisons of Relative Risks of Serious Comorbidities Among Employees with and without Insomnia, GERD, Hepatitis C, Multiple Sclerosis and Chronic Constipation
Brook, R., Kleinman, N., Melkonian, A., Smeeding, J.
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
Toronto, Ontario, Canada
May 5, 2008
Direct cost similarities by point of service for persons with Constipation and Irritable Bowel Syndrome with Constipation in the 6 Months Before and After Diagnosis: An employer perspective
Kleinman, N., Brook, R., Melkonian, A., Evans, S., Talley, N., Baran, R.
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
Toronto, Ontario, Canada
May 5, 2008
An Analysis of Health Benefit Utilization Among Employees with Immune-mediated Inflammatory Diseases
Waters, H., Kleinman, N., Borden, S., Lynch, W., Gardner, H., Rahman, M.
Academy of Managed Care Pharmacy 20th Annual Meeting
San Francisco, CA
April 16-19, 2008
Measuring The Impact Of Cardio-Metabolic Syndrome In An Employed Population And The Relationship Between Performance Compensation And Pharmacy Compliance
Schaneman, J., Kleinman, N., Gardner, H., Hoffman, B.
8th Annual Health Services & Outcomes Research Conference
Kelsey Research Foundation
Houston, Texas
November 7, 2007
Healthcare Cost Comparisons by Point-of-Service for Employees with or without Insomnia
Brook, R., Kleinman, N., Melkonian, A., Doan, J., Smeeding, J., Baran, R.
Academy of Managed Care Pharmacy's (AMCP) 2007 Education Conference
Boston, MA
October 24-27, 2007
Objective Costs and Prevalence of Comorbidities for Persons with and without Insomnia
Doan, J., Brook, R., Kleinman, N., Melkonian, A., Smeeding, J., Baran, R.
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Congress
Dublin, Ireland
October 22, 2007
Medical, Pharmacy, and Sick Leave Costs for Constipation and for Irritable Bowl Syndrome with Constipation in the 6 Months Before and After Diagnosis: An Employer Perspective
Kleinman, N., Brook, R., Melkonian, A., Baran, R., Talley, N.
American College of Gastroenterology Scientific Meeting
Philadelphia, PA
October 2007
Functional Gastrointestinal Disorder Comorbidities: Comparisons of Prevalence and Costs in the 6 Months Before and After Diagnoses of Constipation (C) and Irritable Bowel Syndrome and Constipation (IBS+C)
Brook, R., Talley, N., Kleinman, N., Baran, R.
American College of Gastroenterology Scientific Meeting
Philadelphia, PA
October 2007
Cost of Illness for Insomnia: Medical, Pharmacy, and Work Absence Costs in Employees with and without Insomnia
Brook, R., Kleinman, N., Melkonian, A., Doan, J., Baran, R.
Associated Professional Sleep Societies
Sleep 2007
Minneapolis, MN
June 2007
Comorbidities During the Year Following Diagnosis for Persons with and without GERD using the Agency for Health Research and Quality (AHRQ) 261 Specific Categories
Wallander, M., Wahlqvist, P., Kleinman, N., Campbell, S., Talley, N., Brook, R.
International Society of Pharmacoeconomics and Outcomes Research
Arlington, VA
May 2007
Direct Costs by Point of Service for Persons with and without Constipation: An Employer Perspective
Kleinman, N., Brook, R., Melkonian, A., Baran, R.
Academy of Managed Care Pharmacy 19th Spring Educational Meeting and Showcase
San Diego, CA
April 2007
Cost of Functional Dyspepsia - Results From a Large US Employer Database
George, S., Kleinman, N., Brook, R., Smeeding, J.
Oral Podium Presentation at ISPOR's 9th Annual European Congress
Value in Health
Volume 9, Number 6, Pages A189-90, November/December 2006
Copenhagen, Denmark
October 30, 2006
Cost of Illness for Constipation: Medical, Pharmacy, and Work Absence Costs in Employees with or without Constipation
Brook, R., Kleinman, N., Melkonian, A., Baran, R.
The American College of Gastroenterology Annual Scientific Meeting
Las Vegas, NV
September 2006
Cost of Illness of Gastroesophageal Reflux Disease (GERD): Comparison of Medical, Pharmacy, Sick Leave, Short-and Long-Term Disability, and Workers' Compensation Claims and Medical Claims by Place of Service Between Employees with and without GERD
Brook, R., Campbell, S., Wahlqvist, P., Wallander, M., Kleinman, N., Wiklund, I., Smeeding, J.
Oral Podium Presentation at Digestive Disease Week (The American Gastroenterological Association)
Gastroenterology
Volume 130, Number Suppl 2, Pages A-27
Los Angeles, CA
May 21, 2006
Lost Work Days and Emergency Department Visits Among Patients Treated for Bipolar Disorder
Brook, R., Rajagopalan, K., Novak, S., Kleinman, N., Smeeding, J., Gardner, H.
Oral Podium Presentation at Digestive Disease Week (The American Gastroenterological Association)
American Psychiatric Association
Toronto, Canada; Arlington, VA
May 2006
Impact of the ROME II Criteria - Assessment of Related Comorbid Prevalence and Costs of Patients with Functional Dyspepsia
George, S., Kleinman, N., Brook, R., Smeeding, J.
Digestive Disease Week
Los Angeles, CA
May 2006
Cost of Illness in US Employees with and without Gastroesophageal Reflux Disease (GERD)
Brook, R., Campbell, S., Wahlqvist, P., Wallander, M., Kleinman, N., Wiklund, I., Smeeding, J.
International Society of Pharmacoeconomics and Outcomes Research
Philadelphia, PA
May 2006
The Use of Quintile Analysis as a Measure of Disease Severity: A Comparison within and Across Diseases
Brook, R., Kleinman, N., Smeeding, J., Rajagopalan, K., Wahlqvist, P., Joshua-Gotlib, S., George, S., Campbell, S., Wingenbach, D., Krueger, K., Melkonian, A., Novak, S., Gardner, H.
International Society of Pharmacoeconomics and Outcomes Research
Philadelphia, PA
May 2006
Annual Total Medical Costs for Bipolar Disorder Patients Treated with Antipsychotics
Brook, R., Novak, S., Kleinman, N., Rajagopalan, K., Gardner, H., Smeeding, J.
AMCP Spring Educational Meeting and Showcase
Seattle, WA
April 2006
A Comparison of Average Annual Medical Services for Comorbid Conditions Associated with Metabolic Syndrome Found in Employees with Gout Versus Those without Gout
Novak, S., Patel, P., Kleinman, N., Brook, R., Melkonian, A., Smeeding, J., Joseph-Ridge, N.
AMCP Spring Educational meeting and Showcase
Seattle, WA
April 2006
Cost Comparisons by Place of Service for Persons with and without Gout
Kleinman, N., Patel, P., Brook, R., Melkonian, A., Smeeding, J., Joseph-Ridge, N.
American Society of Health-System Pharmacists Midyear Clinical Meeting
Las Vegas, NV
December 2005
Economic Burden of Gout to the Employer
Kleinman, N., Patel, P., Brook, R., Melkonian, A., Smeeding, J., Joseph-Ridge, N.
Academy of Managed Care Pharmacy 2005 Educational Conference
Nashville, TN
October 2005
Physical and Mental Comorbidities among Employees with Bipolar Disorder: Analysis of AHRQ 261 Specific Categories
Kleinman, N., Rajagopalan, K., Brook, R., Smeeding, J., Gardner, H.
American Psychiatric Association 2005 Annual Meeting
Atlanta, GA
May 2005
Physical and Mental Comorbidities among Employees with Bipolar Disorder: Analysis of Major Diagnostic Categories
Kleinman, N., Gardner, H., Rajagopalan, K., Brook, R., Smeeding, J.
American Psychiatric Association 2005 Annual Meeting
Atlanta, GA
May 2005
Incremental Health Benefits Cost of Bipolar Disorder among Insured Employees
Kleinman, N., Brook, R., Gardner, H., Rajagopalan, K., Smeeding, J.
American Psychiatric Association 2005 Annual Meeting
Atlanta, GA
May 2005
Incremental Health Benefits Cost of Bipolar Disorder among Insured Employees
Kleinman, N., Gardner, H., Rajagopalan, K., Brook, R., Smeeding, J.
International Society for Pharmacoeconomics and Outcomes Research 10th Annual International Meeting
Washington, DC
May 2005
Physical and Mental Comorbidities among Employees with Bipolar Disorder: Analysis of AHRQ 261 Specific Categories
Kleinman, N., Rajagopalan, K., Brook, R., Smeeding, J., Gardner, H.
Academy of Managed Care Pharmacy's 17th Annual Meeting and Showcase
Denver, CO
April 2005
Incremental Health Benefits Cost of Bipolar Disorder among Insured Employees
Kleinman, N., Brook, R., Gardner, H., Rajagopalan, K., Smeeding, J.
Academy of Managed Care Pharmacy's 17th Annual Meeting and Showcase
Denver, CO
April 2005
Impact of Dependents’ Depression on Employee Health Benefits Cost: Quantifying the Burden of Care
Kleinman, N., Muchmore, L., Gardner, H.
Value in Health
Volume 6, Number 3, May/June 2003
International Society for Pharmacoeconomics and Outcomes Research © 2003
Allergy Prevalence, Cost and Productivity Loss in an Insured Employee Population
Kleinman, N., Muchmore, L., Gardner, H., Borden, S.
Value in Health
Volume 6, Number 3, May/June 2003
International Society for Pharmacoeconomics and Outcomes Research © 2003
Family Caregiving Costs for Cancer Patients: A Multi-Employer Analysis
Cremieux, P., Duh, M., Birnbaum, H., Petit, P., Blasi, M., Gardner, H.
Value in Health
Volume 5, Number 3, May/June 2002
Comparisons of Employee Workers' Compensation Costs and Absence Days Using a National Database
Brook, R., Kleinman, N., Melkonian, A., Smeeding, J.
ISPOR 15th Annual International Meeting
May 18, 2010
Atlanta, GA
Poster #PHP45
Functional Dyspepsia Decrease Productivity and Increased Medical Costs
Brook, R., Kleinman, N., Choung, R., Melkonian, A., Smeeding, J., Talley, J.
ISPOR 15th Annual International Meeting
May 17, 2010
Atlanta, GA
Poster #PGI12
Work Absence and Absence Costs in Patients with Osteoarthritis and Low Back Pain in the United States
Vo, P., Brook, R., Kleinman, N., Strassels, S., Smeeding, J., Best, A., Lockhart, E., Marx, S.
29th Annual Scientific Meeting of the American Pain Society
May 6-8, 2010
Baltimore, MD
Poster #131, Abstract id #105
Comparisons of Employee Workers’ Compensation Costs and Absence Days Using a National Database
Brook, R., Kleinman, N., Melkonian, A., Smeeding, J.
To be presented at the Academy of Managed Care Pharmacy (AMCP) 22nd Annual Meeting and Showcase
April 7-10, 2010
San Diego, CA
Work Absence and Absence Costs in Patients with Osteoarthritis (OA) and Low Back Pain (LBP) in the United States
Vo, P., Brook, R., Kleinman, N., Strassels, S., Smeeding, J., Best, A., Lockhart, E., Marx, S.
To be presented at the 29th Annual Scientific Meeting of the American Pain Society
May 6-8, 2010
Baltimore, MD
Poster #131, Abstract id #105
Assessment of Indirect Costs and Absenteeism due to Sick Leave Before and After Treatment Initiation for Multiple Sclerosis (MS) in a US National Database
Rajagopalan, K., Kleinman, N., Brook, R., Beren, I.
Presented at the 25th Congress of European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMs)
September 9 – 12, 2009
Düsseldorf, Germany
The Impact of Hepatitis-C Viral (HCV) Treatment on Work Absence and Productivity
Su, J., Kleinman, N., Brook, R., Melkonian, A., Smeeding, J.,Corey-Lisle, P.
Digestive Disease Week
Chicago, IL
June 1, 2009
Hourly and Annual Objective Productivity (Presenteeism) across Several Diseases: Bipolar Disorder, Other Mental Disorders, Chronic Constipation, Functional Dyspepsia, GERD, Gout, and Insomnia
Brook, R., Kleinman, N., Melkonian, A., Smeeding, J.,
International Society of Pharmacoeconomics and Outcomes Research 14th Annual International Meeting
Orlando, FL
May 20, 2009
Incremental Sick Leave Costs and Lost Time among Employees with Psychiatric and Medical Conditions
Brook, R., Kleinman, N., Melkonian, A., Smeeding, J.
International Society of Pharmacoeconomics and Outcomes Research 14th Annual International Meeting
Orlando, FL
May 19, 2009
The Impact of Multiple Sclerosis on Absenteeism
Brook, R., Kleinman, N., Rajagopalan, K., Melkonian, A.
Consortium of Multiple Sclerosis Centers
Denver, CO
May 30, 2008
Impact of Anti-Tumor Necrosis Factor Therapies on Absence from Work Among Employees with Inflammatory Bowel Disease
Thompson, H., Kleinman, N., Borden, S., Lynch, W., Gardner, H., Rahman, M.
Digestive Disease Week
San Diego, CA
May 17-22, 2008
Absenteeism (lost time) Among Employees with Multiple Sclerosis
Kleinman, N., Brook, R., Rajagopalan, K., Melkonian, A.
Academy of Managed Care Pharmacy 20th Annual Meeting
San Francisco, CA
April 16-19, 2008
Assessment of Work Absence Associated with Insomnia
Kleinman, N., Brook, R., Melkonian, A., Baran, R., Talley, N.
Academy of Managed Care Pharmacy's (AMCP) 2007 Educational Conference
Boston, MA
October 24-27, 2007
Lost Work Days and Emergency Department Visits Among Patients Treated for Bipolar Disorder
Brook, R., Rajagopalan, K., Novak, S., Kleinman, N., Smeeding, J., Gardner, H.
American Psychiatric Association
Toronto, Canada; Arlington, VA
May 2006
Allergy Prevalence, Cost and Productivity Loss in an Insured Employee Population
Kleinman, N., Muchmore, L., Gardner, H., Borden, S.
Value in Health
Volume 6, Number 3, May/June 2003
International Society for Pharmacoeconomics and Outcomes Research © 2003
Work Productivity Loss Among those with Painful Conditions
Novak, S., Joshua-Gotlib, S., Kleinman, N., Brook, R., Krueger, K., Smeeding, J.
American Pain Society
San Antonio, TX
May 2006
Objective Measurement of Hourly and Annual Productivity While at Work in Employees with Gastroesophageal Reflux Disease (GERD) Compared with Employees Without GERD
Wahlqvist, P., Brook, R., Campbell, S., Wallander, M., Kleinman, N., Wiklund, I., Smeeding, J.
Digestive Disease Week
Los Angeles, CA
May 2006
Objective Measurement of Productivity While at Work in US Employees with and without Gastroesophageal Reflux Disease (GERD)
Wahlqvist, P., Brook, R., Campbell, S., Wallander, M., Wiklund, I., Kleinman, N., Smeeding, J.
International Society of Pharmacoeconomics and Outcomes Research
Philadelphia, PA
May 2006
Likelihood of Employment Termination for Employees with Bipolar Disorder Treated with Different Psychotropic Medications
Rajagopalan, K., Kleinman, N., Brook, R., Smeeding, J., Novak, S., Gardner, H.
International Society of Pharmacoeconomics and Outcomes Research
Philadelphia, PA
May 2006
Lost Days and Productivity Impact of Gout
Kleinman, N., Patel, P., Brook, R., Melkonian, A., Smeeding, J., Joseph-Ridge, N.
American College of Rheumatology 2005 Annual Meeting
San Diego, CA
November 2005
Economic Impact of Ablation in Employees and Spouse Dependents with Atrial Fibrillation
Reynolds, M., Rohrbacker, N., Kleinman, N., White, S., March, J.
Poster Presentation at Heart Rhythm 2010
Denver, Colorado
May 12-15, 2010
Abstract #7263
Assessment of Indirect Costs and Absenteeism due to Sick Leave Before and After Treatment Initiation for Multiple Sclerosis (MS) in a US National Database
Rajagopalan, K., Kleinman, N., Brook, R., Beren, I.
Presented at the 25th Congress of European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMs)
September 9 – 12, 2009
Düsseldorf, Germany.
The Impact of Hepatitis-C Viral (HCV) Treatment on Work Absence and Productivity
Su, J., Kleinman, N., Brook, R., Melkonian, A., Smeeding, J., Corey-Lisle, P.
Digestive Disease Week
Chicago, IL
June 1, 2009
Direct Medical Costs and the Likelihood of Health Service Utilization Before and After Initiation of Avonex (Interferon Beta1A-IM) Treatment among Persons with Multiple Sclerosis (MS)
Brook, R., Rajagopalan, K., Kleinman, N., Beren, I.
International Society of Pharmacoeconomics and Outcomes Research 14th Annual International Meeting
Orlando, FL
May 20, 2009
Direct Medical Costs and the Likelihood of Health Service Utilization Before and After Initiation of Avonex (Interferon β1a IM) Treatment Among Persons with Multiple Sclerosis (MS)
Brook, R., Rajagopalan, K., Kleinman, N., Beren, I.
Consortium of MS Centers’ 23rd Annual Meeting
Atlanta, GA
May 27-30, 2009
Medication adherence and the direct medical and prescription cost impact of fixed dose vs loose dose thiazolidinedione combination products among type 2 diabetes patients
Brook, R., Kleinman, N., Wingenbach, D., Bron, M., Pandya, B., Baran, R.
Academy of Managed Care Pharmacy 20th Annual Meeting
San Francisco, CA
April 16-19, 2008
Annual Total Medical Costs for Bipolar Disorder Patients Treated with Antipsychotics
Brook, R., Novak, S., Kleinman, N., Rajagopalan, K., Gardner, H., Smeeding, J.
AMCP Spring Educational Meeting and Showcase
Seattle, WA
April 2006
Likelihood of Employment Termination for Employees with Bipolar Disorder Treated with Different Psychotropic Medications
Rajagopalan, K., Kleinman, N., Brook, R., Smeeding, J., Novak, S., Gardner, H.
International Society of Pharmacoeconomics and Outcomes Research
Philadelphia, PA
May 2006
Changes in Mental Health-Related Insurance Claims Costs Among Patients Treated for Bipolar Disorder
Kleinman, N., Rajagopalan, K., Brook, R., Novak, S., Smeeding, J., Gardner, H.
American Psychiatric Association
Toronto, Canada; Arlington, VA
May 2006
Assessing Fracture Risk with Prescription Drugs in Medicare-Eligible Plan Members of a Telecommunications Company
Erwin, G., Kleinman, N., Astuto, J., Gardner, H., Lipson, J., Stuart, B., Wilson, P.
Value in Health
Volume 5, Number 3, May/June 2002
International Society for Pharmacoeconomics and Outcomes Research © 2003
Incidence and Cost Associated with Pharmacological Treatment for Employees Diagnosed with Urinary and Overactive Bladder Disorders
Muchmore, L., Lynch, W., Gardner, H., Williamson, T.
Value in Health
Volume 5, Number 3, May/June 2002
International Society for Pharmacoeconomics and Outcomes Research © 2003